Bao G - Search Results

1

AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9.

Li A, Tanner MR, Lee CM, Hurley AE, De Giorgi M, Jarrett KE, Davis TH, Doerfler AM, Bao G, Beeton C, Lagor WR. Li A, et al. Among authors: bao g. Mol Ther. 2020 Jun 3;28(6):1432-1441. doi: 10.1016/j.ymthe.2020.04.017. Epub 2020 Apr 19. Mol Ther. 2020. PMID: 32348718 Free PMC article.

2

COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites.

Cradick TJ, Qiu P, Lee CM, Fine EJ, Bao G. Cradick TJ, et al. Among authors: bao g. Mol Ther Nucleic Acids. 2014 Dec 2;3(12):e214. doi: 10.1038/mtna.2014.64. Mol Ther Nucleic Acids. 2014. PMID: 25462530 Free PMC article.

3

Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection.

Cottle RN, Lee CM, Archer D, Bao G. Cottle RN, et al. Among authors: bao g. Sci Rep. 2015 Nov 12;5:16031. doi: 10.1038/srep16031. Sci Rep. 2015. PMID: 26558999 Free PMC article.

4

Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human Genome.

Müller M, Lee CM, Gasiunas G, Davis TH, Cradick TJ, Siksnys V, Bao G, Cathomen T, Mussolino C. Müller M, et al. Among authors: bao g. Mol Ther. 2016 Mar;24(3):636-44. doi: 10.1038/mt.2015.218. Epub 2015 Dec 14. Mol Ther. 2016. PMID: 26658966 Free PMC article.

5

Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off-target Effects in Genome Editing.

Lee CM, Cradick TJ, Fine EJ, Bao G. Lee CM, et al. Among authors: bao g. Mol Ther. 2016 Mar;24(3):475-87. doi: 10.1038/mt.2016.1. Epub 2016 Jan 11. Mol Ther. 2016. PMID: 26750397 Free PMC article. Review.

6

The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells.

Lee CM, Cradick TJ, Bao G. Lee CM, et al. Among authors: bao g. Mol Ther. 2016 Mar;24(3):645-54. doi: 10.1038/mt.2016.8. Epub 2016 Jan 19. Mol Ther. 2016. PMID: 26782639 Free PMC article.

7

A Burden of Rare Variants Associated with Extremes of Gene Expression in Human Peripheral Blood.

Zhao J, Akinsanmi I, Arafat D, Cradick TJ, Lee CM, Banskota S, Marigorta UM, Bao G, Gibson G. Zhao J, et al. Among authors: bao g. Am J Hum Genet. 2016 Feb 4;98(2):299-309. doi: 10.1016/j.ajhg.2015.12.023. Am J Hum Genet. 2016. PMID: 26849112 Free PMC article.

8

Treating hemoglobinopathies using gene-correction approaches: promises and challenges.

Cottle RN, Lee CM, Bao G. Cottle RN, et al. Among authors: bao g. Hum Genet. 2016 Sep;135(9):993-1010. doi: 10.1007/s00439-016-1696-0. Epub 2016 Jun 17. Hum Genet. 2016. PMID: 27314256 Free PMC article. Review.

9

Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.

Lee CM, Zhu H, Davis TH, Deshmukh H, Bao G. Lee CM, et al. Among authors: bao g. Methods Mol Biol. 2017;1498:3-21. doi: 10.1007/978-1-4939-6472-7_1. Methods Mol Biol. 2017. PMID: 27709565

10

Genome editing for inborn errors of metabolism: advancing towards the clinic.

Schneller JL, Lee CM, Bao G, Venditti CP. Schneller JL, et al. Among authors: bao g. BMC Med. 2017 Feb 27;15(1):43. doi: 10.1186/s12916-017-0798-4. BMC Med. 2017. PMID: 28238287 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,171 results

Search Page

Filters